Enquirer Consulting Group

Reachable Buyer Map

Prepared for Nabeel Ahmed · export markets · August 2026
Here is the map. A manufacturer with its own distribution arm inside Pakistan and finished product already moving into eleven export markets has two separate buying audiences. One is the domestic trade. The other is everyone outside the country who buys capacity, a license or finished product rather than a brand, and that second audience is what this page covers: the layers it splits into, the seats that sign inside each one, and roughly how many companies sit there.
Pharmaceutical companies and license holders across ASEAN
The layer already partly open, since finished product already ships into several of these markets. Companies here buy in three different shapes: a license to register and market something they do not make, manufacturing capacity for a molecule they already sell, or finished packs to close a hole in their own line. All three are decided by the same two or three seats.
Who signs: the business development or in-licensing director, the supply chain head, the regulatory affairs director, and the managing director on anything exclusive.
900 to 1,200
licensed manufacturers and marketing authorization holders across the ASEAN member states; national registers publish the two categories inconsistently
Importers and agents across Africa and the Middle East
The widest layer on this page and the one that behaves least like a single market. Registration routes, tender rules and agent exclusivity differ country by country, so it is built one market at a time rather than as a region. Sudan and Kenya sit inside it already, which makes the rest a widening exercise rather than a cold start.
Who signs: the owner or managing director at the importing house, the registration manager who holds the dossier, and the tender desk wherever public supply is involved.
2,000 to 3,000
importers, agents and license holders assembled country by country from national regulator and importer listings
Importers and license holders across Central Asia and the Caucasus
Uzbekistan and Kazakhstan are the entry points, and the neighboring markets run on similar registration logic and similar documentation. Small in company count, slow to register into, and unusually sticky once a dossier is through.
Who signs: the general director at the importing house, the regulatory lead, and the head of the hospital tender desk.
No single regional register
assembled market by market from national medicines agency listings; deliberately a short named list rather than a large one
Brand owners and private label buyers with no plant of their own
Companies that sell medicines or consumer health lines and outsource everything behind the label. They are the natural buyers of spare capacity, and they are also the hardest layer to list, because they sit inside the same registers as everybody else with no code that separates a company that owns a factory from a company that rents one.
Who signs: the founder or commercial director, the head of supply, and the quality lead who audits a site before anything is signed.
Not separately listed
identified one at a time from product registers and label holders rather than filtered out of a list
Institutional, donor and tender procurement
Public health programs, international agencies and NGO supply chains buy on published rules rather than on relationships, and the qualification work is all front-loaded. Slow to enter. Once a site and a dossier are accepted, the volumes look nothing like the private trade.
Who signs: procurement officers at the agency or program, national essential medicines committees, and prequalification and quality assurance leads.
Published, not listed
reached by tracking tender and prequalification notices as they appear rather than by building a buyer list once
Hospital groups and organized pharmacy retail inside Pakistan
From the outside, the domestic side reads as the settled part of this market, given a distribution network with regional depots across the major cities, so this page leaves it alone. It is here for completeness only: hospital groups and chain pharmacy buy on committee cycles and formulary decisions rather than on stock movement, which makes them a different sale from the general trade.
Who signs: the hospital purchase committee, the chief pharmacist, and the chain category buyer.
Described, not counted
no public register separates organized hospital and chain pharmacy buying from the wider domestic trade

Where the openings are

1
Eleven markets is a footprint, not a ceiling. The countries already open share registration logic, documentation language and, in several cases, the same regional importers with the countries next to them. That turns entry into the neighbors into a widening exercise off an existing dossier rather than a cold start, and it is the cheapest growth on this page.
2
Three different products, one conversation. A license, capacity and finished packs are three separate commercial shapes, but inside a buying company they are decided by the same in-licensing and supply seats. One conversation can carry all three, which means the targeting question is which companies, not which offer.
3
The layer that cannot be listed is the one worth watching. Institutional and donor buying is invisible to list building and completely visible in published notices. Watching those publications across several dozen countries is mechanical work, and it is exactly the kind of work that gets skipped in this category when a team is busy shipping orders.
4
The gap in this category is usually distribution, not manufacturing. Making product to standard is the discipline these firms are built on. The machinery that puts a site, its certifications and its line in front of several thousand named in-licensing and supply seats on a schedule, and tracks what comes back, is a separate build, and most manufacturers in this category never make it. That is the part we build, and we hand it over when it works.
Built from public market data, counts banded deliberately. Manufacturer, importer and license holder counts come from national regulator listings and published sector statistics rather than one central source, so they indicate the size of each layer rather than an exact extract. Layers with no register are described rather than counted. It describes the market rather than your business, and there is nothing to buy at the end of it.
ENQUIRER CONSULTING GROUP
enquirerconsulting.com